v3.26.1
Stockholders’ Deficit
12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
Stockholders’ Deficit

Note 9 – Stockholders’ Deficit

 

During 2025, the Company amended its Articles of Incorporation to increase the number of authorized shares of common stock to 1,500,000,000 shares. As of December 31, 2025, there were 425,980,711 shares of common stock issued and outstanding.

 

Stock Issued for Services and Stock-Based Compensation

 

During the year ended December 31, 2025, the Company issued an aggregate of 290,224,658 shares of common stock to officers, employees, consultants, and vendors in exchange for services. The shares were valued at $1,126,671 based on the fair value of the common stock on the respective grant or issuance dates.

 

During the years ended December 31, 2025 and 2024, the Company recognized stock-based compensation expense of $439,054 and $440,256, respectively, related to the vesting of common stock awards issued to the Company’s Chairman and Chief Executive Officer.

 

For additional information regarding common stock issuances during 2023, see the Company’s Annual Report on Form 10-K for the year ended December 31, 2023.